✦ LIBER ✦
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule
✍ Scribed by Dodion, P.; Rozencweig, M.; Nicaise, C.; Piccart, M.; Cumps, E.; Crespeigne, N.; Kisner, D.; Kenis, Y.
- Book ID
- 122011584
- Publisher
- Elsevier Science
- Year
- 1982
- Weight
- 382 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.